W8A Stock Overview
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
Walgreens Boots Alliance, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.07 |
| 52 Week High | US$32.21 |
| 52 Week Low | US$16.47 |
| Beta | 0.75 |
| 1 Month Change | -10.95% |
| 3 Month Change | -17.50% |
| 1 Year Change | -46.82% |
| 3 Year Change | -60.69% |
| 5 Year Change | -64.43% |
| Change since IPO | -49.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| W8A | DE Consumer Retailing | DE Market | |
|---|---|---|---|
| 7D | 3.7% | -1.8% | -2.0% |
| 1Y | -46.8% | -35.5% | -0.3% |
Return vs Industry: W8A underperformed the German Consumer Retailing industry which returned -35.5% over the past year.
Return vs Market: W8A underperformed the German Market which returned -0.3% over the past year.
Price Volatility
| W8A volatility | |
|---|---|
| W8A Average Weekly Movement | 5.7% |
| Consumer Retailing Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: W8A's share price has been volatile over the past 3 months.
Volatility Over Time: W8A's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1909 | 268,500 | Tim Wentworth | www.walgreensbootsalliance.com |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.
Walgreens Boots Alliance, Inc. Fundamentals Summary
| W8A fundamental statistics | |
|---|---|
| Market cap | €14.77b |
| Earnings (TTM) | -€5.67b |
| Revenue (TTM) | €135.75b |
0.1x
P/S Ratio-2.6x
P/E RatioIs W8A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| W8A income statement (TTM) | |
|---|---|
| Revenue | US$144.60b |
| Cost of Revenue | US$117.72b |
| Gross Profit | US$26.88b |
| Other Expenses | US$32.91b |
| Earnings | -US$6.04b |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.00 |
| Gross Margin | 18.59% |
| Net Profit Margin | -4.18% |
| Debt/Equity Ratio | 61.7% |
How did W8A perform over the long term?
See historical performance and comparison